Copyright
©The Author(s) 2020.
World J Clin Cases. Jan 6, 2020; 8(1): 76-87
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.76
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.76
Table 3 Analysis of the correlation between indicators and disease progression
Montreal Cognitive Assessment | r | P value | |||
Aggravation, n = 77 | Stable condition, n = 65 | Improvement, n = 44 | |||
Aβ1-42 in pg/mL | 358.6 ± 38.7 | 364.7 ± 33.9 | 392.5 ± 36.4 | 0.348 | < 0.001 |
T3 in nmol/L | 1.19 ± 0.75 | 1.42 ± 0.66 | 1.48 ± 0.61 | 0.273 | < 0.001 |
FT4 in pmol/L | 14.03 ± 2.86 | 15.15 ± 3.04 | 16.58 ± 2.42 | 0.214 | 0.005 |
- Citation: Mao L, Chen XH, Zhuang JH, Li P, Xu YX, Zhao YC, Ma YJ, He B, Yin Y. Relationship between β-amyloid protein 1-42, thyroid hormone levels and the risk of cognitive impairment after ischemic stroke. World J Clin Cases 2020; 8(1): 76-87
- URL: https://www.wjgnet.com/2307-8960/full/v8/i1/76.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i1.76